• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Testicular acid phosphatase (ACPT), Truncated

ACP10394

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10394 Target NameACP4
Target SynonymsACP4; ACPT; Testicular acid phosphatase; EC 3.1.3.2; Acid phosphatase 4FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BZG2
Background Information
  • Uniprot Id

    Q9BZG2

  • Target Species

    Human

  • Target Name

    ACP4

  • Target Full Name

    Testicular acid phosphatase

  • Target Function

    May dephosphorylate receptor tyrosine-protein kinase ERBB4 and inhibits its ligand-induced proteolytic cleavage. May play a role in odontogenesis.

  • Target Involvement

    Amelogenesis imperfecta 1J (AI1J)

  • Target Subcellular Location

    Membrane; Single-pass type I membrane protein.

  • Target Protein Families

    Histidine acid phosphatase family

  • Target Tissue Specificity

    Expressed mainly in the testis. Also expressed in the brain where they are enriched at the postsynaptic sites. Expressed at lower levels in the trachea, prostate, bone marrow, spinal cord, colon, fetal brain, heart, thymus, fetal liver, spleen, leukocytes

  • Target Synonyms

    ACP4; ACPT; Testicular acid phosphatase; EC 3.1.3.2; Acid phosphatase 4

Inquire Recombinant Human Testicular acid phosphatase (ACPT), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification